Press release
Breast Cancer Screening Market to reach US$ 6,209.25 million and Growing at a CAGR of 4.8% from 2020 to 2027| Koninklijke Philips N.V.., HOLOGIC, INC., BD, MYRIAD GENETICS, INC., SIEMENS HEALTHCARE GMBH, Exact Sciences Corporation
Breast Cancer Screening Market to reach US$ 6,209.25 million and Growing at a CAGR of 4.8% from 2020 to 2027. The growing prevalence of breast cancer and increasing investments in breast cancer management are the major factors driving the breast cancer screening market. However, the high cost of breast cancer screening is a chief factor limiting the market growth. Breast cancer is among the prime causes of deaths in the world, and it is profoundly affecting the quality of life. Thus, it acts as a burden on society if not diagnosed and treated on time. As per the estimations by the American Cancer Society, it is the most common type of cancer in the US as it caused morbidity in ~234,087 people, leading to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, which further led to ~19,376 deaths in that years.Get Sample Copy@: https://bit.ly/3eb80bs
Key Players:
Koninklijke Philips N.V.., HOLOGIC, INC., BD, MYRIAD GENETICS, INC., SIEMENS HEALTHCARE GMBH, Exact Sciences Corporation, ONCOCYTE CORPORATION, POC MEDICAL SYSTEMS, Danaher, GENERAL ELECTRIC
The global breast cancer screening market has been segmented on the basis of test type and end user. The breast cancer screening market, by test type, has been segmented into blood marker tests, imaging test, genetic test, and immunohistochemistry test. The imaging test segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR in the market during the forecast period. Based on end user, the breast cancer screening has been segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019 and is expected to register fastest CAGR during the forecast period.
A few of the essential primary and secondary sources referred to during the preparation of the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, and National Cancer Foundation.
Avail Discount on this report@: https://bit.ly/3iBajbk
Our reports will help clients solve the following issues: β
Insecurity about the future:
Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This help our client invest or divest their assets.
Understanding market opinions:
It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.
Understanding the most reliable investment centers:
Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.
Evaluating potential business partners:
Our research and insights help our clients in identifying compatible business partners.
The research provides answers to the following key questions:
1. What is the estimated growth rate of the market for the forecast period 2020β2027? What will be the market size during the estimated period?
2. What are the key driving forces responsible for shaping the fate of the Breast Cancer Screening market during the forecast period?
3. Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Breast Cancer Screening market?
4. What are the prominent market trends influencing the development of the Breast Cancer Screening market across different regions?
5. What are the major threats and challenges likely to act as a barrier in the growth of the Breast Cancer Screening market?
6. What are the major opportunities the market leaders can rely on to gain success and profitability?
Sameer Joshi
Call: US: +1-646-491-9876, Apac: +912067274191
Email: sales@premiummarketinsights.com
About Premium market insights:
Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Screening Market to reach US$ 6,209.25 million and Growing at a CAGR of 4.8% from 2020 to 2027| Koninklijke Philips N.V.., HOLOGIC, INC., BD, MYRIAD GENETICS, INC., SIEMENS HEALTHCARE GMBH, Exact Sciences Corporation here
News-ID: 2086235 • Views: β¦
More Releases from Premium Market Insights
The Future of HVAC: Trends and Innovations
The Europe HVAC System Market HVAC system market was valued at US$ 50,772.07 million in 2022 and is expected to reach US$ 1,25,024.86 million by 2030; it is estimated to grow at a CAGR of 11.9% from 2022 to 2030.
ππ«ππ πππ
ππ¨ ππ§π¨π° ππ¨π«πβ https://www.businessmarketinsights.com/sample/BMIRE00026922?utm_source=OpenPR&utm_medium=10694
Rise in Demand for Energy-Efficient Solutions Fuel the Europe HVAC System Market
Greenhouse gases are the primary sources of global warming and climate change. These gases absorbβ¦
Automated External Defibrillators Market New Business Opportunities and Investme β¦
The Automated External Defibrillators Market is estimated to reach US$ 2,207.94 million in 2030 from US$ 1,556.21 million by 2030; the market is projected to record a CAGR of 4.5% from 2022 to 2030.
Some of the key driving factors for the automated external defibrillators market growth are the increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. However, performance issues related to automated externalβ¦
Hydrolyzed Collagen Market Types and Applications, Industry Drivers, Future Dema β¦
The Hydrolyzed Collagen Market was valued at US$ 946.43 million in 2022 and is projected to reach US$ 1,322.60 million by 2028; it is expected to register a CAGR of 5.7% from 2022 to 2028.
Various end-use industries are adopting business expansion strategies and scaling production capacity to provide better customer satisfaction. For instance, in July 2020, Rousselot and Giusto Faravelli announced a distribution partnership in Italy, effective from October 2020.β¦
Aroma Ingredients Market Expectations & Growth, Trends Highlighted Until 2028
The Aroma Ingredients Market was valued at US$ 5376.90 million in 2021 and is projected to reach US$ 7692.62 million by 2028; it is expected to grow at a CAGR of 5.2% from 2021 to 2028.
Aroma ingredients are basically isolates of naturally sourced ingredients or chemically produced and are used as ingredients to add aromas or fragrance to various cosmetic and personal care products.
Based on product type, the global aromaβ¦
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by β¦
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingβ¦
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio β¦
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostβ¦
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne β¦
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theβ¦
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve β¦
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:β¦
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance β¦
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchβ¦
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung β¦
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forβ¦